Form 8-K - Current report:
SEC Accession No. 0000950170-24-105164
Filing Date
2024-09-10
Accepted
2024-09-10 16:30:09
Documents
13
Period of Report
2024-09-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tbio-20240910.htm   iXBRL 8-K 43816
2 EX-99.1 tbio-ex99_1.htm EX-99.1 13755
3 GRAPHIC img44325073_0.jpg GRAPHIC 4733
  Complete submission text file 0000950170-24-105164.txt   190184

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20240910.xsd EX-101.SCH 26957
16 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20240910_htm.xml XML 5103
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 241290410
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)